Filing Details
- Accession Number:
- 0001127602-25-001727
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-22 16:10:01
- Reporting Period:
- 2025-01-21
- Accepted Time:
- 2025-01-22 16:10:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1145197 | Insulet Corp | PODD | Surgical & Medical Instruments & Apparatus (3841) | 043523891 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1731734 | Eric Benjamin | C/O Insulet Corporation 100 Nagog Park Acton MA 01720 | Evp, Cpxpo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-01-21 | 1,704 | $46.22 | 20,406 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2025-01-21 | 3,371 | $74.50 | 23,777 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-01-21 | 12,394 | $280.00 | 11,383 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2025-01-21 | 1,704 | $0.00 | 1,704 | $46.22 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2025-01-21 | 3,371 | $0.00 | 3,371 | $74.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,271 | 2027-02-22 | No | 4 | M | Direct | |
| 1,875 | 2028-02-14 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to an existing Rule 10b5-1 trading plan.
- This option, which is fully vested, vested over a four-year period with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters.
Billionaire Hedge Funds
